{"name":"Aerpio Therapeutics","slug":"aerpio-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOTlQzRkpQQlZDZXVlTFU3RzJWVV9HN3RhdWxyQ1gxdGJDaHFvZWpFQy1tOWRDbXhESDk2RkVWajdQZ2NhSTFncGlxTF9WTEVXMTdYZlhWdmd6NVI3b1FTbGdCZjNGTXBrVWp3S19GUF9DZlh0OFF3RXI0cU1XMFZhVXFzZjJZVkNpUU95bm9Jc0Y3Sm9yMkFoQ1dTTzNPb29PY0MwZ2VWaXJNR3d0WHgtY1BXV0FFWlMzZFRwdGl6VmR5U2xGMUNSLTRLdm9UQ2p6dVlvYU1BemYySTVLTE5va3ZFdmxvb0thRXNUNzlCVWJld0VuUDZn?oc=5","date":"2025-09-09","type":"pipeline","source":"PR Newswire","summary":"Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight - PR Newswire","headline":"Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQUXFKOVo5OXI3NW5CQ1BsZTVtQnRSU0UwWTVWQW9jTG41US0wWWJ2SlRQWFdhY19xcGlleTNNRUsxekJXckwzblRlWnRkTDR1NnRJX0F6TjQ1MGZ5QlVsMFNBRk9UOTFQdUlpeTVPRWsxT1FVaF9qcXkyY0RkdWw2clZKbGJzQ1VBREdBMDEwd2VQcUZLWldYQVRfRVBVNXNsMHQ1RA?oc=5","date":"2025-03-18","type":"pipeline","source":"Fierce Pharma","summary":"Aadi Bioscience takes flight with new moniker: Whitehawk Therapeutics - Fierce Pharma","headline":"Aadi Bioscience takes flight with new moniker: Whitehawk Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTFBmb3U1Z2xkeVNBaVMtbzNPLTZmMnZXWHlnNEJHTkdFeEx4VG5IY2l3dDZVSnV4NlJnX2M1X2Fodk5lYk1scWlRMWU1VGt2YjU3WHkyR3Aya0pfaHBaZmlySHpZbw?oc=5","date":"2022-12-20","type":"pipeline","source":"GuruFocus","summary":"Dhaval Desai Net Worth (2026) - GuruFocus","headline":"Dhaval Desai Net Worth (2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxObDFhYWdaNGtwc1JITnN0Q01PdFNnWXVFYU1jQUdob2puclVtMmJOaGxoLWEzRHJVcmk4VmtTRW9CUGdGWk82ZGpBcnpJVlZwVHVDT0J3VUhheHJ0NUtkQzdmZnd0T1I5UEJwVkh0THMzUDRaMFFCZEdMRkRsWkFiaU5FT1gwZG5lU2RyR19pVWM?oc=5","date":"2021-08-27","type":"deal","source":"The Business Journals","summary":"Merger deal finalized; Cincinnati loses public company - The Business Journals","headline":"Merger deal finalized; Cincinnati loses public company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNdGxDdjJWVDJjSVBZZ0RoYzMyTk9ia2hxczRkYVRkenFJWGE3aGRJSTJuSmJUTnRta2M5Q1E4UFFyYll1ZGgwQ0tNY3hURm4wZlZmR3lHZm8tSUtCUl9XLU9WRFBfR3RKNExsUFJUcXpwOWRYb2NRSFhXUmV5a2hMdml4ZmNZU2hYWjFwSmtCTTB4dERlWmVObEg1NzRmRTdlbGoxS2dobHYtN0d2ZUQzU0I2QmZXWXNJNFkybnotR0wzOVd5cEc4OFAtM2w4SVJ5MWRQLUdSVUtuTEloQzg1Ry12dmdFbHpkbHdpcHZWV0hLZDhrY2xMczUxOXJvNEk?oc=5","date":"2021-08-26","type":"deal","source":"GlobeNewswire","summary":"Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement - GlobeNewswire","headline":"Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOVXVub3VhM2t3bVYySXBzSG1CeFF1R2ozZkRYZTU4bVdnZHp2LUFqV0NIT0V0Z21Mb0tDQ0NFemYwajFPYmItMGZOcHVwNnJIVndwY0dRZC1DZjNGcktzamNrRWV5djQzbmpwRTd4YURVQmtwSjN2SnUySWNZNFY2TjdlWGpTSFdhZy1JN3lTeVVwbms5T1lWZEp6LWxlLThM?oc=5","date":"2021-07-30","type":"deal","source":"Law Street Media","summary":"Aerpio Pharma, Directors Sued After Aadi Merger Announcement - Law Street Media","headline":"Aerpio Pharma, Directors Sued After Aadi Merger Announcement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiSEFVX3lxTE5BdkNOLU9HNVFVNUh5NDRBb0dNalBWOWVnZ3ZpLVlTS3lHeHkxOWtyamJ2WDVEVURiSU1ibU5WUEtNWTh2a3NNNg?oc=5","date":"2020-12-04","type":"deal","source":"StockInvest.us","summary":"Aerpio Pharmaceuticals Stock Price Forecast. Should You Buy ARPO? - StockInvest.us","headline":"Aerpio Pharmaceuticals Stock Price Forecast. Should You Buy ARPO?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQVjIyOWRSSkdaemZZcDNaWk5XTFN6T1hCMGNLNDB4TjJfQmM5aVd4YVB1UjBHUGczbmtkWkRSNlBNSV9jbFhSUjJhZFlCX0g5NVhHNVlIYUxsNDRVTmJ5cEV6dk5FWTRMZWVnYzNGTTNzWnU1cE43TTJLMmxndzlIdzlLWXFDYi1fR1paWDFHNEk?oc=5","date":"2020-08-03","type":"pipeline","source":"Ophthalmology Times","summary":"Glaucoma medications: Getting down to the basics - Ophthalmology Times","headline":"Glaucoma medications: Getting down to the basics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOdWdIMnBuNTRRSTA1LWFiZmpMWTYwaDBMdWo5VDc0bU8tQ09RYXZocFdremdfWUxqN3B1MXByY2JOeWNwTV9kbktWUUVuenhBak5lWXRZbnplZENMY3RWQklMcHFDWlg5azFNbjdwakZhQVlZMUZOcW95cm40ZVM1dUxFNjk4Zkp1V1ZycFU4ZnRWaDdPSWs2eWt0MWNuM2w1?oc=5","date":"2019-10-21","type":"pipeline","source":"Fierce Biotech","summary":"Aerpio may hang the 'for sale' sign up, axes CEO after eye drug flop - Fierce Biotech","headline":"Aerpio may hang the 'for sale' sign up, axes CEO after eye drug flop","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPaVA3YXNhR05oSElEMThCWlRycldHNzVuUkNvOV9UcGRQWFdubkprQlc2Z2ZESjdJSkFJWVlUOFQwOVlObmZZMXRHdnBwNlRtbkwwcFVGOFlIM3B6dHcyZVdQTGhLSXI2bW5qX3dkMUtTdTRudjFia2ZZeG9fM0JsWnBhYW1VQlN2ZkZBNl9hdV9nWlRVVkM5RURMUjNzUy1XWHo3eXM0NDNZQmJndW11V2xiQU0wY1ZDQ1E?oc=5","date":"2018-07-23","type":"pipeline","source":"Fierce Biotech","summary":"Gossamer Bio nets $230M in series B to advance portfolio against undisclosed targets - Fierce Biotech","headline":"Gossamer Bio nets $230M in series B to advance portfolio against undisclosed targets","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}